C.01.041.3. The pharmacist to whom a prescription for a Schedule F Drug is transferred under section C.01.041.1 shall retain in his files for a period of two years the information and documents referred to in section C.01.041.2.
- SOR/78-424, s. 3.
C.01.041.4. A pharmacist who transfers a prescription under section C.01.041.1
(a) shall enter on the original of the prescription or in a suitable record of prescription kept under the name of each patient, the date of transfer; and
(b) shall not make any further sales under the prescription nor transfer it to another pharmacist.
- SOR/78-424, s. 3.
C.01.042. (1) No person shall refill a prescription for a Schedule F Drug unless the practitioner so directs and no person shall refill such a prescription more times than the number of times prescribed by the practitioner.
(2) The person filling or refilling a prescription for a Schedule F Drug shall enter on the original of the prescription or in a suitable record of prescriptions kept under the name of each patient
(a) the date of filling;
(b) the date of each refill, if applicable;
(c) the quantity of drug dispensed at the original filling and each refill; and
(d) his name.
- SOR/78-424, s. 4.
C.01.043. (1) A person may sell a Schedule F Drug, without having received a prescription therefor, to
(a) a drug manufacturer;
(b) a practitioner;
(c) a wholesale druggist;
(d) a registered pharmacist;
(e) a hospital certified by the Department of National Health and Welfare;
(f) a Department of the Government of Canada or of a province, upon receipt of a written order signed by the Minister thereof or his duly authorized representative; or
(g) any person, upon receipt of a written order signed by the Director.
(2) Where a person makes a sale authorized by paragraph (1)(f) or (1)(g), he shall retain the written order for the drug for a period of at least two years from the date of filling the order.
C.01.044. (1) Where a person advertises to the general public a Schedule F Drug, the person shall not make any representation other than with respect to the brand name, proper name, common name, price and quantity of the drug.
(2) Subsection (1) does not apply where
(a) the drug is listed in Part II of Schedule F; and
(b) the drug is
(i) in a form not suitable for human use, or
(ii) labelled in the manner prescribed by paragraph C.01.046(b).
- SOR/78-424, s. 5;
- SOR/93-202, s. 7;
- SOR/93-407, s. 3.
- Date modified: